Alzheimer's Drug Discovery Foundation

5.7K posts

Alzheimer's Drug Discovery Foundation

@TheADDF

The Alzheimer's Drug Discovery Foundation's mission is to rapidly accelerate the discovery and development of drugs to prevent, treat, and cure #Alzheimers.

New York, NY Katılım Şubat 2009

4.8K Takip Edilen18.6K Takipçiler

Sabitlenmiş Tweet

Alzheimer's Drug Discovery Foundation@TheADDF·11 Mar

The ADDF has appointed Isobel Coleman as Chief Executive Officer. A global leader across government, nonprofit & private sectors, she will guide the next era of Alzheimer’s research, advancing combination therapies & precision medicine. Read more: bit.ly/4lkx4B2

Alzheimer's Drug Discovery Foundation tweet media

English

471

Alzheimer's Drug Discovery Foundation@TheADDF·18h

Advances in blood-based biomarkers are making it possible to identify Alzheimer’s through a routine blood draw, potentially years before symptoms appear. Through ADDF’s DxA, we’re advancing next-generation diagnostics to expand access & accelerate trials. nytimes.com/2026/03/19/wel…

English

464

Alzheimer's Drug Discovery Foundation retweetledi

Phyllis Ferrell@PhylFerrell·18h

@TheADDF’s perfectly polished, interim CEO, Jane McIntosh, welcomes #ADPD2026 attendees to their packed reception - so thankful for her #leadership! @adpdnet

English

139

Alzheimer's Drug Discovery Foundation@TheADDF·1d

Inflammation is a key driver of disease progression in FTD. A new publication from our funded investigator, @CoyaTx, highlights how regulatory T cell dysfunction and systemic inflammation may contribute to disease biology, reinforcing the potential of immune-targeted approaches.

Coya Therapeutics@CoyaTx

Today, Coya announced the publication of a research study demonstrating the involvement of the peripheral immune system in the neuroinflammatory profile of frontotemporal dementia (#FTD). Dr. Fred Grossman, Chief Medical Officer at Coya said, “We believe these biomarker data coupled with the clinical and lab results of the clinical study in FTD provide additional evidence supporting the development of biologic combination therapies that enhance the function of regulatory T cells and target inflammation in FTD, ALS and other neurodegenerative diseases of high unmet need.” For more details: businesswire.com/news/home/2026…

English

293

Alzheimer's Drug Discovery Foundation@TheADDF·3d

This phase includes continued commitments from the initial funders, as well as @biogen, Dolby Family Ventures,@EliLillyandCo, and the Shanahan Family Foundation, along with new support from the JTMF Foundation and the Robertson Foundation.

English

105

Alzheimer's Drug Discovery Foundation@TheADDF·3d

The ADDF is launching DxA 3.0 to advance next-gen biomarkers: blood tests for tau and co-pathologies, integrated multi-marker panels, and AI tools capturing the full biological complexity of Alzheimer's to accelerate drug development. Read more: bit.ly/3NDoAIV

English

308

Alzheimer's Drug Discovery Foundation retweetledi

Phyllis Ferrell@PhylFerrell·3d

@TheADDF’s Melissa Lee gives a dynamite presentation at #ADPD2026 about the potential for #Speech as an #Alzheimers #diagnostic and explains one of the biggest investments in the #DiagnosticAccelerator collaboration with Gates Ventures. @adpdnet

English

173

Alzheimer's Drug Discovery Foundation retweetledi

Phyllis Ferrell@PhylFerrell·3d

Excellent panel on #gender at @TheADDF and @AlzData #Alzheimers summit at #ADPD2026. How do we take a more scientifically robust approach to understand the impact of disease on women, especially with #menopause transitions? Chaired by the indefatigable @MiiaKivipelto @adpdnet

English

182

Alzheimer's Drug Discovery Foundation retweetledi

Phyllis Ferrell@PhylFerrell·3d

@TheADDF, Jane McIntosh, announces another $50 million in investment in #Alzheimers #diagnostics at #ADPD2026. Let’s goooooooo!!!! #DxA3 @adpdnet

English

160

Alzheimer's Drug Discovery Foundation@TheADDF·3d

Stanford Medicine Magazine recently featured Goodes Prize winner Dr. Frank Longo, whose team developed LM11A-31, a neuroprotective drug designed to shield brain cells from damage in #Alzheimer’s. stanmed.stanford.edu/drug-slow-alzh…

English

229

Alzheimer's Drug Discovery Foundation@TheADDF·9 Mar

The ADDF & @HarringtonDI_UH are pleased to announce the 2027 ADDF-Harrington Scholar Award, aimed at accelerating the translation of innovative research that may treat, prevent, slow, or reverse Alzheimer's or related dementias. Learn more: bit.ly/2rEQkiv

English

297

Alzheimer's Drug Discovery Foundation@TheADDF·5 Mar

The ADDF’s Cognitive Vitality program was recently featured in @FT. Our neuroscientists review the scientific evidence behind potential interventions for brain health, evaluating possible benefits, risks, and the gaps that still exist in the research. ft.com/content/0f682c…

English

217

Alzheimer's Drug Discovery Foundation retweetledi

The AFTD@AFTDHope·3 Mar

Two requests for proposals are now OPEN from AFTD and @TheADDF! 🔴 Treat FTD Fund - LOI due March 30 🔴 Accelerating Drug Discovery for FTD - LOI due May 11 Learn more and apply today: bit.ly/4rplnux

English

243

Alzheimer's Drug Discovery Foundation@TheADDF·2 Mar

Alzheimer’s research is entering its most transformative era yet, and the ADDF is shaping the next generation of breakthroughs. Read more in our 2025 Annual Report: 2025report.alzdiscovery.org

English

291

Alzheimer's Drug Discovery Foundation@TheADDF·26 Şub

Better diagnostics will accelerate drug development & ultimately deliver better outcomes for patients. Dr. @SuzanneESchind1 highlights the importance of biomarkers in guiding combination therapies, much like in cancer care. vumedi.com/video/consider…

English

374

Alzheimer's Drug Discovery Foundation@TheADDF·24 Şub

ADDF-supported Biomarker Observatory has released the first comprehensive analysis of biomarker use across Alzheimer’s clinical trials. With 70%+ of drugs targeting novel pathways, next- gen biomarkers are key to combination therapies & precision medicine. bit.ly/4aMrJO3

English

1.5K

Alzheimer's Drug Discovery Foundation retweetledi

CTAD@CTADconference·23 Şub

Funding Alert: FTD Research Opportunities @TheADDF & @AFTDHope announce funding for frontotemporal degeneration research: 🔹Treat FTD Fund: Up to $2.5M for phase 0-2 trials 🔹Accelerating Drug Discovery: Avg $300K for drug development Apply here : mailchi.mp/alzdiscovery/r… #FTD

English

341

Alzheimer's Drug Discovery Foundation retweetledi

WashU Medicine@washumedicine·20 Şub

For families facing Alzheimer’s, scientific progress matters. That’s why we’re proud to announce Randy Bateman, MD, has received the Goodes Prize for work including the first Alzheimer’s blood test and leadership of the landmark DIAN-TU prevention trials.

Alzheimer's Drug Discovery Foundation@TheADDF

Congratulations to Dr. Randy Bateman of @washumedicine, this year’s Goodes Prize recipient. His pioneering work in Alzheimer’s diagnostics, clinical trials, and new AI tools has helped reshape the field. bit.ly/3Mhku8R

English

1.8K

Alzheimer's Drug Discovery Foundation@TheADDF·20 Şub

A simple blood test may help build a predictive “clock” estimating when Alzheimer’s symptoms begin — a step forward for earlier intervention. This work underscores the DxA’s mission to advance accessible tools for timely and accurate diagnosis. wapo.st/3ZN2m9P

English

206

Alzheimer's Drug Discovery Foundation@TheADDF·20 Şub

The approval of monoclonal antibodies marked an important milestone, paving the way for broader innovation. Today, 75% of drugs in development target novel pathways with increasing focus on tau and the underlying biology of the disease. cen.acs.org/pharmaceutical…

English

302

Keşfet

@adpdnet @CoyaTx @biogen @EliLillyandCo @AlzData @MiiaKivipelto @HarringtonDI_UH @FT